WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

Amgen

AmgenAmgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

www.amgen.com

Amgen RSS Channel

Filters
List of articles in category Amgen
Title Published Date
Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 23 April 2011
Amgen's First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion 21 April 2011
Amgen Establishes Commercial Operations in Brazil 11 April 2011
Amgen Donates $1 Million to Help Japanese Disaster Victims 14 March 2011
Breakaway From Cancer(R) Launches Newly-Enhanced Website 03 March 2011
Results Published in The Lancet Demonstrate Superiority of XGEVA(TM) (Denosumab) 27 February 2011
Boehringer Ingelheim to Purchase Amgen's Fremont (California) Facility 18 January 2011
Amgen and Xencor Enter Option Deal to Co-Develop Xencor's Novel Antibody for Autoimmune Diseases 06 January 2011
XGEVA(TM) (Denosumab) Significantly Improved Bone Metastasis-Free Survival 14 December 2010
Three Innovative Ideas Receive $10,000 Prizes in Patients | Choices | Empowerment Competition 08 December 2010
Amgen's Nplate(R) Maintains Platelet Counts for More Than Five Years in Adults with Chronic ITP 05 December 2010
Amgen, Pfizer, and World-Class Professional Golfer Phil Mickelson Announce Partnership 06 November 2010
Prolia(TM) (denosumab) Receives Best New Drug Honor at Scrip Awards 05 November 2010
Denosumab Delays the Onset of Bone Complications Compared to Zometa 11 October 2010
Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis(TM)' 23 September 2010
Amgen Announces Top-Line Results of Phase 3 Head and Neck Cancer Trial 11 August 2010
FDA Grants Priority Review Designation to Denosumab 19 July 2010
Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients 15 July 2010
34 Teachers and Schools Across North America Receive $10,000 Amgen Award 23 June 2010
FDA Approves Amgen's Prolia(TM) (Denosumab) for Treatment of Postmenopausal Women with Osteoporosis 03 June 2010
  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next
  • End

Business & Industry

  • Pfizer to acquire Global Blood Therapeutics for $5.4 billion to enhance presence in rare hematology
  • Roche's subcutaneous formulation of Tecentriq demonstrates positive Phase III results
  • Bayer Consumer Health leaders propose new principles for science-led self-care
  • GSK signs agreement to support pandemic preparedness in Europe
  • Pfizer and BioNTech advance COVID-19 vaccine strategy with study start of next-generation vaccine candidate based on enhanced spike protein design

Research & Development

  • Scientists create long-acting injectable drug delivery system for tuberculosis
  • Treating cancer by sticking cells in place
  • Vitamin K prevents cell death: a new function for a long-known molecule
  • Disparities in United States COVID-19 vaccine distribution
  • New needle-free nasal vaccine shows promise for COVID-19
  • Scientists develop new biomimetic formulation for treating glioblastoma
  • SARS-CoV-2 hijacks nanotubes between neurons to infect them

Conferences & Events

  • New approach to treatment of deadly kidney cancer
  • SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference

Regulatory Affairs

  • FDA approves first systemic treatment for alopecia areata
  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  1. You are here:  
  2. Home
  3. Amgen

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.